Eli Lilly and Company vs The Goldman Sachs Group, Inc.
Eli Lilly and Company is worth $1.061T, 3.5× the $302.952B market cap of The Goldman Sachs Group, Inc.. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $1.061T | $302.952B |
| Global rank | #1 | #2 |
| Share price | $1,189.41 | $1,040.46 |
| Change | -2.11% | +0.58% |
| Revenue | $65.179B | $58.283B |
| Net income | $20.640B | $17.176B |
| Country | United States | United States |
| Sector | Healthcare | Financial Services |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Eli Lilly and Company bigger than The Goldman Sachs Group, Inc.?
- Eli Lilly and Company has a market cap of $1.061T against $302.952B for The Goldman Sachs Group, Inc., making it 3.5 times as valuable.
- Which company earns more, LLY or GS?
- Eli Lilly and Company reported net income of $20.640B and The Goldman Sachs Group, Inc. reported $17.176B in their most recent annual periods.